Skip to content

Strigolactones and Dysplastic Colonic Lesions or Cancer

The Effect of the Plant Hormones Strigolactones on Cultures of Dysplastic Colonic Lesions and Cancer

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02824835
Enrollment
150
Registered
2016-07-07
Start date
2016-07-31
Completion date
2017-12-31
Last updated
2016-07-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colonic Neoplasms, Colonic Polyps

Brief summary

The purpose of this study is to determine the effects of the plant hormones strigolactones, on cell cultures of colonic polyps and colorectal cancer.

Detailed description

Strigolactones have been shown to anti-proliferative and pro-apoptotic effects in cell cultures of breast and prostate origin, partially by down-regulation of cyclin B1 and induction of cell cycle arrest. In this study the investigators intend to take biopsies from benign colonic polyps and cancer tissue, culture intestinal explants and generate immortalized primary cells as a platform to assess the effect of this plant hormone on cell viability, cell mobility, apoptosis and cytoskeleton modifications.

Interventions

PROCEDUREbiopsy during colonoscopy

sampling the lesion with forcept biopter

Sponsors

Meir Medical Center
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Patients with positive findings during colonoscopy

Exclusion criteria

* Patients below 18 years old * Patients who cannot sign a consent form

Design outcomes

Primary

MeasureTime frameDescription
percentage of cells with reduced viability after dose-dependent exposure24 hours of exposure to strigolactone
percentage of cells in G2/M arrest after dose-dependent exposure24 hours of exposure to strigolactoneanalysis of cell cycle

Contacts

Primary ContactIdo Laish, MD
ido.lish@clalit.org.il+ 972-9-7473261

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026